HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Inflammation promotes adipocyte lipolysis via IRE1 kinase.

Abstract
Obesity associates with inflammation, insulin resistance, and higher blood lipids. It is unclear if immune responses facilitate lipid breakdown and release from adipocytes via lipolysis in a separate way from hormones or adrenergic signals. We found that an ancient component of ER stress, inositol-requiring protein 1 (IRE1), discriminates inflammation-induced adipocyte lipolysis versus lipolysis from adrenergic or hormonal stimuli. Our data show that inhibiting IRE1 kinase activity was sufficient to block adipocyte-autonomous lipolysis from multiple inflammatory ligands, including bacterial components, certain cytokines, and thapsigargin-induced ER stress. IRE1-mediated lipolysis was specific for inflammatory triggers since IRE1 kinase activity was dispensable for isoproterenol and cAMP-induced lipolysis in adipocytes and mouse adipose tissue. IRE1 RNase activity was not associated with inflammation-induced adipocyte lipolysis. Inhibiting IRE1 kinase activity blocked NF-κB activation, interleukin-6 secretion, and adipocyte-autonomous lipolysis from inflammatory ligands. Inflammation-induced lipolysis mediated by IRE1 occurred independently from changes in insulin signaling in adipocytes, suggesting that inflammation can promote IRE1-mediated lipolysis independent of adipocyte insulin resistance. We found no role for canonical unfolded protein responses or ABL kinases in linking ER stress to IRE1-mediated lipolysis. Adiponectin-Cre-mediated IRE1 knockout in mice showed that adipocyte IRE1 was required for inflammatory ligand-induced lipolysis in adipose tissue explants and that adipocyte IRE1 was required for approximately half of the increase in blood triglycerides after a bacterial endotoxin-mediated inflammatory stimulus in vivo. Together, our results show that IRE1 propagates an inflammation-specific lipolytic program independent from hormonal or adrenergic regulation. Targeting IRE1 kinase activity may benefit metabolic syndrome and inflammatory lipid disorders.
AuthorsKevin P Foley, Yong Chen, Nicole G Barra, Mark Heal, Kieran Kwok, Akhilesh K Tamrakar, Wendy Chi, Brittany M Duggan, Brandyn D Henriksbo, Yong Liu, Jonathan D Schertzer
JournalThe Journal of biological chemistry (J Biol Chem) 2021 Jan-Jun Vol. 296 Pg. 100440 ISSN: 1083-351X [Electronic] United States
PMID33610548 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Cytokines
  • Insulin
  • Membrane Proteins
  • NF-kappa B
  • Ern2 protein, mouse
  • Protein Serine-Threonine Kinases
Topics
  • 3T3-L1 Cells
  • Adipocytes (metabolism, physiology)
  • Adipose Tissue (metabolism)
  • Animals
  • Cytokines (metabolism)
  • Inflammation (metabolism)
  • Insulin (metabolism)
  • Insulin Resistance (physiology)
  • Lipolysis (physiology)
  • Macrophages (metabolism)
  • Membrane Proteins (genetics, metabolism, physiology)
  • Mice
  • NF-kappa B (metabolism)
  • Obesity (metabolism)
  • Phosphorylation
  • Protein Serine-Threonine Kinases (genetics, metabolism, physiology)
  • Signal Transduction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: